Specialized Medical Co.

  • Market Cap: N/A
  • Industry: Hospital
  • ISIN: SA16B0CHUPH2
SAR
18.60
18.6 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
382.69
379.96
368.90
328.30
383.27
356.33
363.07
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
382.69
379.96
368.90
328.30
383.27
356.33
363.07
Raw Material Cost
286.87
284.21
280.40
278.91
248.64
255.53
268.94
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.39
13.02
12.15
12.48
13.82
13.45
12.22
Selling and Distribution Expenses
21.92
47.17
47.83
11.32
61.30
36.46
32.76
Other Expenses
-1.24
-1.30
-1.21
-1.25
-1.38
-1.35
-1.22
Total Expenditure (Excl Depreciation)
308.79
331.39
328.23
290.24
309.94
291.98
301.70
Operating Profit (PBDIT) excl Other Income
73.89999999999999
48.6
40.7
38.1
73.3
64.3
61.4
Other Income
6.98
2.56
2.61
2.81
1.58
1.99
2.14
Operating Profit (PBDIT)
104.56
74.27
65.64
64.28
74.91
87.57
84.79
Interest
12.39
13.02
12.15
12.48
13.82
13.45
12.22
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
95.82
95.75
88.50
49.39
134.63
100.80
94.13
Depreciation
23.68
23.13
22.35
23.42
0.00
21.24
21.28
Profit Before Tax
68.49
38.12
31.14
28.39
61.09
52.89
51.29
Tax
2.25
1.76
1.50
2.23
2.17
1.94
2.09
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
66.25
36.36
29.64
26.16
58.91
50.94
49.21
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
66.25
36.36
29.64
26.16
58.91
50.94
49.21
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
66.25
36.36
29.64
26.16
58.91
50.94
49.21
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,058.23
992.35
856.36
827.10
907.64
0.00
0.00
Earnings per share (EPS)
0.27
0.15
0.12
0.1
0.24
0.2
0.2
Diluted Earnings per share
0.27
0.15
0.12
0.1
0.24
0.2
0.2
Operating Profit Margin (Excl OI)
19.31%
12.78%
11.03%
11.59%
19.13%
18.06%
16.9%
Gross Profit Margin
24.09%
16.12%
14.5%
15.78%
15.94%
20.8%
19.99%
PAT Margin
17.31%
9.57%
8.03%
7.97%
15.37%
14.3%
13.55%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 0.71% vs 3.01% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 81.87% vs 22.97% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 36.12% vs 13.81% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -4.62% vs 7.44% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Specialized Medical Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SAR)
Change(%)
Net Sales
382.69
0
382.69
Other Operating Income
0.00
0.00
0.00
Total Operating income
382.69
0
382.69
Raw Material Cost
286.87
0
286.87
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.39
0
12.39
Selling and Distribution Expenses
21.92
0
21.92
Other Expenses
-1.24
0.00
-1.24
Total Expenditure (Excl Depreciation)
308.79
0
308.79
Operating Profit (PBDIT) excl Other Income
73.90
0.00
73.90
Other Income
6.98
0
6.98
Operating Profit (PBDIT)
104.56
0
104.56
Interest
12.39
0
12.39
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
95.82
0
95.82
Depreciation
23.68
0
23.68
Profit Before Tax
68.49
0
68.49
Tax
2.25
0
2.25
Provisions and contingencies
0
0
0.00
Profit After Tax
66.25
0
66.25
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
66.25
0
66.25
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
66.25
0
66.25
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,058.23
0
1,058.23
Earnings per share (EPS)
0.27
0
0.27
Diluted Earnings per share
0.27
0
0.27
Operating Profit Margin (Excl OI)
19.31%
0%
0.00
19.31%
Gross Profit Margin
24.09%
0%
0.00
24.09%
PAT Margin
17.31%
0%
0.00
17.31%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 38.27 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.71% vs 3.01% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -0.16% vs 19.26% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.62 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 81.87% vs 22.97% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 12.39% vs 65.45% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.76 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 36.12% vs 13.81% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 33.15% vs 54.64% in Sep 2024

Quarterly - Interest
Interest 1.24 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -4.62% vs 7.44% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -10.14% vs 6.98% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.31%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024